Qube Research & Technologies LTD Viatris Inc Transaction History

Qube Research & Technologies LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$11.27 - $13.53 $3.41 Million - $4.09 Million	302,289 New	302,289 $3.61 Million
Q3 2023 Nov 13, 2023	BUY	$9.59 - $11.35 $5.9 Million - $6.98 Million	615,176 Added 541.83%	728,713 $7.19 Million
Q2 2023 Aug 14, 2023	SELL	$9.02 - $10.29 $28.6 Million - $32.6 Million	-3,170,445 Reduced 96.54%	113,537 $1.13 Million
Q1 2023 May 15, 2023	BUY	$9.2 - $12.26 $22.2 Million - $29.5 Million	2,409,478 Added 275.53%	3,283,982 $31.6 Million
Q4 2022 Feb 14, 2023	SELL	$8.72 - $11.56 $1.96 Million - $2.6 Million	-224,917 Reduced 20.46%	874,504 $9.73 Million
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $9.32 Million - $12.2 Million	1,099,421 New	1,099,421 $9.37 Million
Q1 2022 May 09, 2022	SELL	$9.81 - $15.4 $1.79 Million - $2.81 Million	-182,379 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$12.09 - $14.68 $2.2 Million - $2.68 Million	182,379 New	182,379 $2.47 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.